The State of Texas Top Legal Officer Sues Acetaminophen Makers Over Autism Allegations

Courtroom Case
Ken Paxton, a Trump ally campaigning for US Senate, claimed the drug companies of concealing the risks of acetaminophen

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, claiming the firms concealed alleged dangers that the medication created to children's neurological development.

The lawsuit arrives four weeks after Donald Trump advocated an unsubstantiated connection between using Tylenol - also known as paracetamol - while pregnant and autism in offspring.

Paxton is taking legal action against J&J, which once produced the drug, the exclusive pain medication recommended for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he stated they "deceived the public by profiting off of pain and promoting medication ignoring the dangers."

Kenvue states there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, stated.

Kenvue stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the welfare of American women and children."

On its online platform, the company also mentioned it had "regularly reviewed the relevant science and there is lacking reliable evidence that shows a established connection between using paracetamol and autism."

Groups representing doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has said paracetamol - the key substance in Tylenol - is among limited choices for expectant mothers to treat pain and fever, which can pose major wellness concerns if not addressed.

"In multiple decades of studies on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any stage of gestation results in brain development issues in offspring," the group said.

The lawsuit references recent announcements from the former administration in arguing the drug is potentially dangerous.

In recent weeks, the former president generated worry from health experts when he advised pregnant women to "resist strongly" not to consume acetaminophen when unwell.

Federal regulators then published an announcement that medical professionals should contemplate reducing the usage of acetaminophen, while also stating that "a direct connection" between the drug and autism spectrum disorder in young ones has remains unverified.

Health Secretary RFK Jr, who oversees the Food and Drug Administration, had pledged in spring to conduct "extensive scientific investigation" that would establish the origin of autism in a short period.

But authorities advised that identifying a single cause of autism spectrum disorder - believed by scientists to be the result of a intricate combination of inherited and external influences - would be difficult.

Autism is a form of permanent neurological difference and impairment that impacts how people perceive and interact with the world, and is identified using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is campaigning for federal office - claims the manufacturer and J&J "willfully ignored and tried to quiet the evidence" around acetaminophen and autism.

The lawsuit attempts to require the companies "destroy any promotional materials" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit echoes the complaints of a group of guardians of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

A federal judge dismissed the lawsuit, stating investigations from the plaintiffs' authorities was inconclusive.

Danny Dominguez
Danny Dominguez

Elara is a seasoned sports analyst with a passion for data-driven betting strategies and years of industry experience.